Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children
Authors
Moormann, Ann M.Chelimo, Kiprotich
Sumba, Peter Odada
Tisch, Daniel J.
Rochford, Rosemary A.
Kazura, James W.
Document Type
Journal ArticlePublication Date
2007-02-15Keywords
AdolescentAnimals
Burkitt Lymphoma
Child
Child, Preschool
Herpesvirus 4, Human
Humans
Kenya
Malaria, Falciparum
Plasmodium falciparum
T-Lymphocytes
Biostatistics
Epidemiology
Health Services Research
Immunology and Infectious Disease
Pediatrics
Metadata
Show full item recordAbstract
BACKGROUND: Malaria and Epstein-Barr virus (EBV) infection are cofactors in the pathogenesis of endemic Burkitt lymphoma (eBL). The mechanisms by which these pathogens predispose to eBL are not known. METHODS: Healthy Kenyan children with divergent malaria exposure were measured for responses to EBV latent and lytic antigens by interferon (IFN)- gamma enzyme-linked immunospot (ELISPOT) assay and interleukin (IL)-10 ELISA. Phytohemagglutinin (PHA), purified protein derivative (PPD), and T cell epitope peptides derived from merozoite surface protein (MSP)-1, a malaria blood-stage antigen, were also evaluated. RESULTS: Children 5-9 years old living in an area holoendemic for malaria had significantly fewer EBV-specific IFN- gamma responses than did children of the same age living in an area with unstable malaria transmission. This effect was not observed for children <5 years old or those >9 years old. In contrast, IFN- gamma responses to PHA, PPD, and Plasmodium falciparum MSP-1 peptides did not significantly differ by age. IL-10 responses to EBV lytic antigens, PPD, and PHA correlated inversely with malaria exposure regardless of age. CONCLUSIONS: Children living in malaria-holoendemic areas have diminished EBV-specific T cell immunosurveillance between the ages of 5 and 9 years, which coincides with the peak age incidence of eBL.Source
J Infect Dis. 2007 Mar 15;195(6):799-808. Epub 2007 Feb 6. Link to article on publisher's siteDOI
10.1086/511984Permanent Link to this Item
http://hdl.handle.net/20.500.14038/47254PubMed ID
17299709Related Resources
Link to Article in PubMedRights
© 2007 by the Infectious Diseases Society of America.ae974a485f413a2113503eed53cd6c53
10.1086/511984